Anticoagulation for perioperative thromboprophylaxis in people with cancer.

CONCLUSIONS: We found no difference between perioperative thromboprophylaxis with LMWH versus UFH and LMWH compared with fondaparinux in their effects on mortality, thromboembolic outcomes, major bleeding, or minor bleeding in people with cancer. There was a lower incidence of wound hematoma with LMWH compared to UFH.
PMID: 29993117 [PubMed - as supplied by publisher]

Source: Cochrane Database of Systematic Reviews - July 11, 2018 Category: General Medicine Authors: Matar CF, Kahale LA, Hakoum MB, Tsolakian IG, Etxeandia-Ikobaltzeta I, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA Tags: Cochrane Database Syst Rev Source Type: research